Left ventricular mural thrombus

Insights

Long-term anticoagulation may be beneficial for patients with left ventricular aneurysm and mural thrombus. Early detection of high-risk myocardial infarction patients is crucial for preventing complications like left ventricular aneurysm and mural thrombus.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Thrombosis Research

Background:

  • Mural thrombus formation is a known complication of myocardial infarction and cardiomyopathy.
  • Left ventricular aneurysm can develop following large, transmural myocardial infarctions.
  • Anticoagulation is a potential therapeutic strategy but carries inherent risks.

Purpose of the Study:

  • To review the indications for anticoagulation in patients with left ventricular aneurysm and mural thrombus.
  • To identify patient groups at high risk for developing left ventricular aneurysm and mural thrombus after myocardial infarction.
  • To discuss the risks and benefits of anticoagulation in these patient populations.

Main Methods:

  • Review of existing literature and clinical guidelines.
  • Analysis of patient data regarding mural thrombus development and anticoagulation outcomes.
  • Risk-benefit assessment of anticoagulant therapy in specific clinical scenarios.

Main Results:

  • Mural thrombus in left ventricular aneurysm warrants consideration of long-term anticoagulation.
  • Serial noninvasive imaging is recommended for high-risk myocardial infarction patients to detect aneurysm/thrombus.
  • Anticoagulants are advised for mural thrombi complicating infarction and in congestive cardiomyopathy.

Conclusions:

  • Anticoagulation is a key consideration for mural thrombus in left ventricular aneurysm and congestive cardiomyopathy.
  • Risk stratification and individualized assessment are essential before initiating anticoagulant therapy.
  • Balancing the benefits of anticoagulation against bleeding risks is critical for patient management.

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...